Strax

Autospela

Adoptive cell therapy for Melanoma using tumour infiltrating lymphocytes: John Bridgeman

23 Visningar • 07/30/23
Dela med sig
Bädda in
administrator
administrator
Prenumeranter
0

A look at the use of TIL in Melanoma and future TIL engineering strategies. John Bridgeman is the Director of Cell Therapy Research at Immetacyte Ltd

Visa mer
0 Kommentarer sort Sortera efter
Facebook-kommentarer

Strax

Autospela